HomeADPT • NASDAQ
add
Adaptive Biotechnologies Corp
Previous close
$16.12
Day range
$15.11 - $16.56
Year range
$6.26 - $20.74
Market cap
2.48B USD
Avg Volume
1.78M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 71.68M | 51.04% |
Operating expense | 138.24M | -3.34% |
Net income | -13.58M | 59.70% |
Net profit margin | -18.94 | 73.32% |
Earnings per share | -0.09 | 60.46% |
EBITDA | -8.58M | 70.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 226.98M | 2.11% |
Total assets | 512.74M | -4.94% |
Total liabilities | 287.74M | -14.59% |
Total equity | 225.00M | — |
Shares outstanding | 153.98M | — |
Price to book | 11.35 | — |
Return on assets | -6.37% | — |
Return on capital | -7.48% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.58M | 59.70% |
Cash from operations | 2.06M | 116.45% |
Cash from investing | -8.25M | -137.31% |
Cash from financing | 21.66M | 16,953.54% |
Net change in cash | 15.46M | 58.49% |
Free cash flow | 3.60M | -13.43% |
About
CEO
Founded
2009
Headquarters
Website
Employees
624
